For the methylation analysis of single CpGs within the IGF2 amplicon, we could observe a significant hypermethylation in 14 out of 17 PPHP patients at specific CpGs (Figure2B) (Z-test, p<0.05). The gene discussed is IGF2; the disease is pseudopseudohypoparathyroidism.